Comparison of clinical outcome, cartilage turnover, and inflammatory activity following either intra-articular or a combination of intra-articular with intra-osseous platelet-rich plasma injections in osteoarthritis knee: A randomized, clinical trial
In brief
A single-blind randomised trial at an Indian teaching hospital compared platelet-rich plasma (PRP) injected into the knee joint, PRP injected into the joint and underlying bone, and saline, in moderately advanced knee osteoarthritis. The authors report that both PRP approaches improved pain and knee scores over saline and lowered some inflammation and cartilage-breakdown markers in the short term.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Comparison of clinical outcome, cartilage turnover, and inflammatory activity following either intra-articular or a combination of intra-articular with intra-osseous platelet-rich plasma injections in osteoarthritis knee: A randomized, clinical trial Authors: Apurba Barman, Debapriya Bandyopadhyay, Sudipta Mohakud, Jagannatha Sahoo, Rituparna Maiti, Somnath Mukherjee, Satya Prakash, Sankha Subhra Roy, Amrutha Viswanath Link: https://pubmed.ncbi.nlm.nih.gov/36414504/ Year of Publication: 2023
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

